Abstract

Chronic venous disease is one of the most discussed diagnoses in surgery and occurs in about 25-50% of the adult population. The high prevalence of chronic venous disease in our country underlines the importance of accurate and modern diagnosis of this pathology, the need to use treatment technologies that can be applied as widely as possible, not only by cardiovascular doctors, phlebologists, but also specialists in general surgery and even doctors of other specialties. The Detralex line of drugs was created for the treatment of venous diseases: varicose veins and hemorrhoids. Detralex helps to relieve pain, swelling and heaviness in the legs in chronic venous disease, and in addition, helps to eliminate the symptoms of both acute and chronic hemorrhoids: discomfort, pain and bleeding.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call